These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The National Center for Advancing Translational Sciences' Intramural Training Program and Fellow Career Outcomes. Haynes B; Brimacombe K; Hare C; Faupel-Badger J CBE Life Sci Educ; 2020 Dec; 19(4):ar51. PubMed ID: 33001768 [TBL] [Abstract][Full Text] [Related]
6. NIH center struggles to speed new therapies. Kaiser J Science; 2019 Sep; 365(6460):1363. PubMed ID: 31604250 [No Abstract] [Full Text] [Related]
7. Battle over rare disease drug ensnares NIH. Wadman M Science; 2016 Oct; 354(6308):18-19. PubMed ID: 27846474 [No Abstract] [Full Text] [Related]
8. The NCATS Assay Guidance Manual programme: advancing the practice and rigour of preclinical translation. Markossian S; Brimacombe KR; Sittampalam GS; Grossman A; Coussens NP; Inglese J; Auld DS; Chin W; Austin CP; Hall MD Nat Rev Drug Discov; 2022 Dec; 21(12):863-864. PubMed ID: 36253455 [No Abstract] [Full Text] [Related]
9. Diversity, equity and inclusion actions from the NCATS Clinical and Translational Science awarded programs. Boulware LE; Vitale A; Ruiz R; Corbie G; Aguilar-Gaxiola S; Wilkins CH; Egede LE Nat Med; 2022 Sep; 28(9):1730-1731. PubMed ID: 35764682 [No Abstract] [Full Text] [Related]
10. Validating ADME QSAR Models Using Marketed Drugs. Siramshetty V; Williams J; Nguyễn ÐT; Neyra J; Southall N; Mathé E; Xu X; Shah P SLAS Discov; 2021 Dec; 26(10):1326-1336. PubMed ID: 34176369 [TBL] [Abstract][Full Text] [Related]
11. Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates. Southan C; Williams AJ; Ekins S Drug Discov Today; 2013 Jan; 18(1-2):58-70. PubMed ID: 23159359 [TBL] [Abstract][Full Text] [Related]
12. Revisiting Repurposing. Sharlow ER Assay Drug Dev Technol; 2016 Dec; 14(10):554-556. PubMed ID: 27982703 [TBL] [Abstract][Full Text] [Related]
13. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications. DiMasi JA Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388 [TBL] [Abstract][Full Text] [Related]
14. Keeping It Clean: The Cell Culture Quality Control Experience at the National Center for Advancing Translational Sciences. Roth JS; Lee TD; Cheff DM; Gosztyla ML; Asawa RR; Danchik C; Michael S; Simeonov A; Klumpp-Thomas C; Wilson KM; Hall MD SLAS Discov; 2020 Jun; 25(5):491-497. PubMed ID: 32233736 [TBL] [Abstract][Full Text] [Related]
15. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease. Shoaib M; Kamal MA; Rizvi SMD Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531 [TBL] [Abstract][Full Text] [Related]
16. Computational and experimental advances in drug repositioning for accelerated therapeutic stratification. Shameer K; Readhead B; Dudley JT Curr Top Med Chem; 2015; 15(1):5-20. PubMed ID: 25579574 [TBL] [Abstract][Full Text] [Related]